MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Effect of piperacillin- tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial (vol 320, pg 984, 2018)

被引：4
|
作者：
Harris, P. N. A.
Tambyah, P. A.
Lye, D. C.
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2019年 / 321卷 / 23期
关键词：
D O I：
10.1001/jama.2019.6706
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2370 / 2370
页数：1
相关论文
共 1 条
  • [1] Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance A Randomized Clinical Trial
    Harris, Patrick N. A.
    Tambyah, Paul A.
    Lye, David C.
    Mo, Yin
    Lee, Tau H.
    Yilmaz, Mesut
    Alenazi, Tamer H.
    Arabi, Yaseen
    Falcone, Marco
    Bassetti, Matteo
    Righi, Elda
    Rogers, Benjamin A.
    Kanj, Souha
    Bhally, Hasan
    Iredell, Jon
    Mendelson, Marc
    Boyles, Tom H.
    Looke, David
    Miyakis, Spiros
    Walls, Genevieve
    Al Khamis, Mohammed
    Zikri, Ahmed
    Crowe, Amy
    Ingram, Paul
    Daneman, Nick
    Griffin, Paul
    Athan, Eugene
    Lorenc, Penelope
    Baker, Peter
    Roberts, Leah
    Beatson, Scott A.
    Peleg, Anton Y.
    Harris-Brown, Tiffany
    Paterson, David L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (10): : 984 - 994
1